Fig. 2.
SMOC2 promotes Ang II-treated VSMCs proliferation and migration. Ang II-treated VSMCs were transfected with ov-SMOC2 or si-SMOC2. (A, B) the transfect efficiency was evaluated using qPCR and Western blot. *p<0.05 compared to control group. (C, D) CCK-8 and Transwell assays were used to detect the proliferation and migration of Ang II-treated VSMCs. One-way ANOVA was used for statistical analysis. *p<0.05 compared to control group; #p<0.05 compared to Ang II group.